1. Investigation of Potentially Deleterious Alleles for Response to Cancer Treatment with 5-Fluorouracil
- Author
-
Giovanna Chaves, Cavalcante, Natalle Do Socorro Da Costa, Freitas, André Maurício, Ribeiro-Dos-Santos, Darlen Cardoso, De Carvalho, Ellen Moreno, Da Silva, Paulo Pimentel, De Assumpção, Ândrea, Ribeiro-Dos-Santos, Sidney, Santos, and Ney Pereira Carneiro, Dos Santos
- Subjects
Male ,Polymorphism, Genetic ,Orotate Phosphoribosyltransferase ,Orotidine-5'-Phosphate Decarboxylase ,Black People ,Antineoplastic Agents ,Thymidylate Synthase ,White People ,Asian People ,Gene Frequency ,Multienzyme Complexes ,Neoplasms ,Humans ,Female ,Fluorouracil ,Tumor Suppressor Protein p53 ,Alleles ,Brazil ,Dihydrouracil Dehydrogenase (NADP) - Abstract
To investigate polymorphisms that are probable indicators of response variability during cancer treatment with 5-fluorouracil (rs16430, rs2279198, rs1801159 and rs17878362).We investigated 1,038 individuals regarding allele distribution from different populations, out of which we genotyped 127 individuals from a Brazilian admixed population. Similarity analyses with parental populations were performed. Prevalence of potentially deleterious alleles was also evaluated.Thirty-seven percent of the population had at least three potentially deleterious alleles and 38.6% had at least one potentially deleterious allele in homozygosis.Potentially deleterious alleles are present under diverse frequencies in different populations. Therefore, genotyping prior to 5-fluorouracil administration should be recommended.
- Published
- 2015